Opus Genetics.

Opus Genetics raised an additional $4.5 million, following its $19 million capital round in 2021. Investors include Foundation Fighting Blindness FD fund, the Manning Family Foundation and Bios Partners. It is...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT